The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents

Journal of Medicinal Chemistry
Yong LiuHenry W Pauls

Abstract

The acetamido and carboxamido substituted 3-(1H-indazol-3-yl)benzenesulfonamides are potent TTK inhibitors. However, they display modest ability to attenuate cancer cell growth; their physicochemical properties, and attendant pharmacokinetic parameters, are not drug-like. By eliminating the polar 3-sulfonamide group and grafting a heterocycle at the 4 position of the phenyl ring, potent inhibitors with oral exposure were obtained. An X-ray cocrystal structure and a refined binding model allowed for a structure guided approach. Systematic optimization resulted in novel TTK inhibitors, namely 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides. Compounds incorporating the 3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl bicyclic system were potent (TTK IC50 < 10 nM, HCT116 GI50 < 0.1 μM), displayed low off-target activity (>500×), and microsomal stability (T(1/2) > 30 min). A subset was tested in rodent PK and mouse xenograft models of human cancer. Compound 75 (CFI-401870) recapitulated the phenotype of TTK RNAi, demonstrated in vivo tumor growth inhibition upon oral dosing, and was selected for preclinical evaluation.

References

Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·P DuesbergR Hehlmann
Aug 23, 2002·Journal of Medicinal Chemistry·Astrid SasseHolger Stark
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Harold A FiskMark Winey
May 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Geert J P L KopsDon W Cleveland
Nov 19, 2004·Nature·Harith Rajagopalan, Christoph Lengauer
Dec 25, 2004·The Journal of Biological Chemistry·Jen-Hsuan WeiSheau-Yann Shieh
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bibo YuanEdward Gabrielson
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mei LengYi Wang
Sep 29, 2006·Journal of Medicinal Chemistry·Gregory L WarrenMartha S Head
Jan 16, 2007·The Journal of Organic Chemistry·Deshou JiangYufen Zhao
Nov 6, 2007·Cancer Research·Giuliana SalvatoreMassimo Santoro
May 13, 2008·Nature Cell Biology·Zhenye YangConly L Rieder
Jun 26, 2008·The Journal of Organic Chemistry·Kelvin L Billingsley, Stephen L Buchwald
Jan 6, 2009·Journal of Cellular and Molecular Medicine·Wei WangXuedong Liu
Jun 18, 2009·Journal of Chemical Information and Modeling·Miklos Feher, Christopher I Williams
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Apr 13, 2010·Nature Chemical Biology·Nicholas KwiatkowskiNathanael S Gray
Jul 14, 2010·The Journal of Cell Biology·Laura HewittStephen S Taylor
Aug 12, 2010·Journal of Chemical Information and Modeling·Miklos Feher, Christopher I Williams
Mar 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jewel DanielEdward Gabrielson
Jul 5, 2011·Bioorganic & Medicinal Chemistry Letters·Marina CaldarelliRiccardo Colombo
Oct 11, 2011·Cancer Discovery·Rachel BroughAlan Ashworth
Jan 25, 2012·Nature Reviews. Genetics·David J GordonDavid Pellman
Mar 3, 2012·Journal of Chemical Information and Modeling·Miklos Feher, Christopher I Williams
Apr 10, 2012·Annual Review of Biochemistry·Xuedong Liu, Mark Winey
May 29, 2012·Bioorganic & Medicinal Chemistry Letters·D Vijay KumarRobert O Carlson
Dec 22, 2012·Nature Reviews. Molecular Cell Biology·Emily A Foley, Tarun M Kapoor
Apr 20, 2013·Current Opinion in Pharmacology·Marieke AartsNicholas C Turner
Aug 13, 2013·Cell Death and Differentiation·M JemaàG Kroemer
Jul 12, 2012·ACS Medicinal Chemistry Letters·Ken-Ichi KusakabeYusuke Nakamura

❮ Previous
Next ❯

Citations

Mar 9, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jacqueline M MasonTak W Mak
Jun 5, 2018·ChemMedChem·Jinyun DongShaoshun Li
Feb 16, 2016·Beilstein Journal of Organic Chemistry·Tarn C Johnson, Stephen P Marsden
Nov 11, 2016·MedChemComm·Jae-Hyun ParkYusuke Nakamura
Jul 22, 2018·Current Medicinal Chemistry·Aysegul HanikogluTomris Ozben
Jul 31, 2019·Molecular Cancer Therapeutics·Lin ZhengEthan Dmitrovsky
Dec 17, 2019·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Nadia G ZakiGehad G Mohamed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.